ArticleCellular oncology (Dordrecht, Netherlands)2013

siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells.

Fatemeh Bagheri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.